Seagen Inc. is a biotechnology company focused on developing innovative cancer therapies. With a strong portfolio of targeted antibody-drug conjugates (ADCs), the company is dedicated to transforming the lives of patients suffering from cancer. Seamlessly integrating cutting-edge science and technology, Seagen Inc. is poised to make a significant impact in the field of oncology.
